Blue Cross Blue Shield of North Dakota (BCBSND) regularly develops and revises medical policies in response to rapidly changing medical technology. Our commitment is to update the provider community as medical policies are adopted and/or revised. Benefit determinations are made based on the medical policy in effect at the time of service.
The following medical policies were reviewed by the Internal Medical Policy Committee on July 22, 2020.
Please see policy for changes. Medical policies are available at www.bcbsnd.com/web/providers/policies.
The following medical policies are new:
- Percutaneous Left Atrial Appendage Closure Devices
- Transcatheter Mitral Valve Repair Replacement
- Radiofrequency Ablation of Peripheral Nerves to Treat Chronic Knee Pain
- Biochemical Markers of Bone Remodeling
- Discectomy
- Arthrex Bovine Collagen
The following medical policies were revised:
- Feeding Disorder Program
- Manipulations
- Cardiac Application of Positron Emission Tomography Scanning
- Experimental/Investigational Services
- Cosmetic and Reconstruction Services
- Allergy Immunotherapy
- Eustachian Tube Balloon Dilation
- Gastric Electrical Stimulation, Gastric Pacing
- Bone Mineral Density Studies
- High Resolution Anoscopy (HRA)
- Home Cervical Traction Therapy
The following medical policies had coding changes:
- Durable Medical Equipment
- Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
- Removal of Benign and Premalignant Skin Lesions
- Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults
- Bioengineered Skin Substitutes
- Amniotic Membrane Amniotic Fluid
- Ilizarov Bone Lengthening
- Hematopoietic Cell Transplantation for CNS Embryonal Tumors and Ependymoma
- Myoelectric Prosthetic Components for the Upper Limb
The following medical policy will be retired: